CLARKE JOHN K

ATYR

CLARKE JOHN K serves as Director at aTyr Pharma, Inc. (ATYR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$10.8K

Net Position

Net Seller

$10.8K

Companies Traded

ATYR

Active Period

May 2021

1 total trades

Most Recent

Sell ATYR

May 21, 2021 · $10.8K

CLARKE JOHN K's Insider Trading at aTyr Pharma, Inc. (ATYR)

Buys

0 · $0.00

Sells

1 · $10.8K

Total Shares Bought

Total Shares Sold

2,500

ATYR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 21, 2021	Sell	2,500	$4.34	$10.8K	0

Related Insiders

Jill Marie Broadfoot

officer: Chief Financial Officer

ATYRSell · Feb 4, 2026

DENYES NANCY

officer: General Counsel

ATYRSell · Feb 4, 2026

Sanjay Shukla

President and CEO

ATYRSell · Feb 4, 2026

SCHIMMEL PAUL

Director

ATYRBuy · Oct 8, 2025

Explore More Insider Trading Data

ATYR Insider Trading Activity

View all insider trades at aTyr Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity